BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2863219)

  • 1. [Technics for intramuscular injections of delayed-action neuroleptics].
    Bélanger-Annable MC
    Infirm Can; 1985 Sep; 27(8):26-9. PubMed ID: 2863219
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-acting neuroleptics: technique for intramuscular injection.
    Bélanger-Annable MC
    Can Nurse; 1985 Sep; 81(8):41-3. PubMed ID: 2862986
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment with neuroleptics in psychiatry.
    Shepherd M; Watt DC
    Curr Dev Psychopharmacol; 1977; 4():215-47. PubMed ID: 23248
    [No Abstract]   [Full Text] [Related]  

  • 4. Postbasic nursing procedures. 1. Giving depot neuroleptic drugs.
    Nurs Mirror; 1982 Apr; 154(16):42-3. PubMed ID: 6123107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
    Salvesen C; Vaksdal K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
    [No Abstract]   [Full Text] [Related]  

  • 6. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
    arap Mengech HN; Wazome EG
    East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expert opinion on APAP (Prolonged action atypical antipsychotic agents). Conclusion].
    Guelfi JD
    Encephale; 2009 Jan; Suppl 3():S123-4. PubMed ID: 19268182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
    Costentin J
    Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
    [No Abstract]   [Full Text] [Related]  

  • 10. [Local muscle reaction after injection of depot neuroleptics or antiparkinson drugs. Experimental study in rabbits with injection at the same injection site].
    Svendsen O
    Ugeskr Laeger; 1983 Aug; 145(35):2660-2. PubMed ID: 6137893
    [No Abstract]   [Full Text] [Related]  

  • 11. Why change injection sites for depot antipsychotic medication?
    Cox A; Emmerson B; Collyer B; Scott J
    Aust N Z J Psychiatry; 2012 Aug; 46(8):794. PubMed ID: 22495954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Foreword].
    Guelfi JD; Costentin J; Terra JL
    Encephale; 2009 Jan; Suppl 3():S85-6. PubMed ID: 19268183
    [No Abstract]   [Full Text] [Related]  

  • 13. Injection of depot antipsychotic medications in patients with schizophrenia.
    Fleishman M
    J Clin Psychiatry; 2002 Sep; 63(9):840-1; author reply 841-2. PubMed ID: 12363128
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of depot injection techniques.
    Quartermaine S; Taylor R
    Nurs Times; 1995 Jul 26-Aug 1; 91(30):36-9. PubMed ID: 7644369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Withdrawal of delayed-action neuroleptics in psychotic patients].
    Maillard M; Coutanceau R; Marchina JC
    Ann Med Psychol (Paris); 1979; 137(3-4):351-5. PubMed ID: 40514
    [No Abstract]   [Full Text] [Related]  

  • 16. Is depot medication safe in the setting of myopathy?
    Price JR; Bastiampillai T; Dhillon RS
    Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801
    [No Abstract]   [Full Text] [Related]  

  • 17. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
    Chéreau I; Gorwood P; Mouchabac S
    Encephale; 2009 Jan; Suppl 3():S97-100. PubMed ID: 19268186
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
    Dassa D; Lacambre M; Vacheron MN
    Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.